Newsletter
Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

The Real Chemistry Podcast

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research,…
October 18, 2018

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O’Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute

Cancer Research Institute is a pioneer in using immunotherapy to treat cancer. This week’s guest, Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, discusses the future of oncology research, the upcoming CRI Awards Gala, what it’s like working alongside a Nobel Prize winner, and her love of baking.

 

You may also like

Subscribe to Health Podcast Network and never miss new Episodes!

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp